• Health In Tech Q2 revenue fell to $8.1 million from $9.3 million a year earlier.
• Net results swung to a $2.5 million loss, or $(0.04) per diluted share, from $0.6 million profit, or $0.01.
• Adjusted EBITDA (non-GAAP) turned to a $1.3 million loss from $1.6 million profit.
• Contracted revenue totaled $32.3 million as of June 30; pipeline revenue reached $66.3 million as of July 31.
• CEO Tim Johnson cited investments in sales, marketing, and talent; HitRix marketplace platform remains slated for a second-half launch.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Health in Tech Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608131630PR_NEWS_USPR_____CN25149) on August 13, 2026, and is solely responsible for the information contained therein.